|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02652 CF PHARMTECH
Nominal 
() | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 96,459 | 116,292 | 45,467 |
| Net Cash from / (used in) Investing Activities | (113,437) | (127,652) | (151,422) |
| Net Cash from / (used in) Financing Activities | 28,690 | 7,875 | (5,409) |
| Increase / (Decrease) in Cash & Cash Equivalents | 11,712 | (3,485) | (111,364) |
| Cash & Cash Equivalents at beginning of period | 70,612 | 74,838 | 183,285 |
| Effect of Foreign Exchange Rate Changes | (387) | (741) | 2,917 |
| Others | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 81,937 | 70,612 | 74,838 |
| Remarks: | Real time quote last updated: 30/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 21,088 |
| %Change | -33.531% |
| EPS / (LPS) | RMB 0.060 |
| NBV Per Share (¥) | RMB -- |